Free Trial
→ How War with China Could Start in 128 Days (From Behind the Markets) (Ad) Buy IPX Stock  Free IPX Stock Alerts

IperionX (IPX) Financials

IperionX logo
$19.76 +0.97 (+5.16%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$19.64 -0.13 (-0.63%)
As of 04/17/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for IperionX

Annual Income Statements for IperionX

This table shows IperionX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -44 -35 -44
Consolidated Net Income / (Loss)		 -22 -17 -22
Net Income / (Loss) Continuing Operations		 -22 -17 -22
Total Pre-Tax Income 		-22 -17 -22
Total Operating Income		 -22 -17 -22
Total Gross Profit		 -7.99 -2.18 -3.43
Total Revenue		 0.40 0.49 0.55
Operating Revenue		 0.40 0.49 0.55
Total Cost of Revenue		 8.39 2.68 3.98
Operating Cost of Revenue		 8.39 2.68 3.98
Total Operating Expenses		 14 15 18
Selling, General & Admin Expense		 3.06 3.99 4.52
Research & Development Expense		 4.28 8.26 12
Exploration Expense		 6.19 2.83 1.95
Other Operating Expenses / (Income)		 0.00 0.19 -0.41
Total Other Income / (Expense), net		 0.00 0.00 0.00
Income Tax Expense		 0.00 0.00 0.00
Basic Earnings per Share		 ($0.16) ($0.11) ($0.10)
Weighted Average Basic Shares Outstanding		 - - 257.24M
Diluted Earnings per Share		 ($0.16) ($0.11) ($0.10)
Weighted Average Diluted Shares Outstanding		 - - 257.24M
Weighted Average Basic & Diluted Shares Outstanding		 - - 257.24M

Quarterly Income Statements for IperionX

No quarterly income statements for IperionX are available.

Annual Cash Flow Statements for IperionX

This table details how cash moves in and out of IperionX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Net Change in Cash & Equivalents		 21 32 62
Net Cash From Operating Activities		 3.78 4.95 23
Net Cash From Continuing Operating Activities		 3.78 4.95 23
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income		 -0.43 -1.51 0.72
Changes in Operating Assets and Liabilities, net		 4.22 6.46 22
Net Cash From Investing Activities		 -2.82 -2.71 -8.07
Net Cash From Continuing Investing Activities		 -2.82 -2.71 -8.07
Purchase of Property, Plant & Equipment		 -0.89 -2.08 -5.02
Sale of Property, Plant & Equipment		 -1.93 -0.63 -3.05
Net Cash From Financing Activities		 20 29 48
Net Cash From Continuing Financing Activities		 20 29 48
Repayment of Debt		 -0.00 -0.01 -0.01
Issuance of Debt		 0.04 0.00 0.00
Issuance of Common Equity		 20 30 48
Other Financing Activities, net		 -0.08 -0.51 -0.42
Other Net Changes in Cash		 -0.22 -0.06 -0.24

Quarterly Cash Flow Statements for IperionX

No quarterly cash flow statements for IperionX are available.

Annual Balance Sheets for IperionX

This table presents IperionX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024
Total Assets		 23 55
Total Current Assets		 13 42
Cash & Equivalents		 12 33
Accounts Receivable		 0.23 2.30
Inventories, net		 0.00 0.02
Prepaid Expenses		 0.59 6.07
Plant, Property, & Equipment, net		 3.99 7.77
Plant, Property & Equipment, gross		 3.99 7.77
Total Noncurrent Assets		 6.06 6.11
Other Noncurrent Operating Assets		 6.06 6.11
Total Liabilities & Shareholders' Equity		 23 55
Total Liabilities		 2.24 4.10
Total Current Liabilities		 1.65 3.05
Short-Term Debt		 0.38 0.45
Accounts Payable		 1.18 2.32
Other Current Liabilities		 0.08 0.29
Total Noncurrent Liabilities		 0.59 1.04
Long-Term Debt		 0.59 1.04
Total Equity & Noncontrolling Interests		 21 51
Total Preferred & Common Equity		 21 51
Total Common Equity		 21 51
Common Stock		 59 113
Retained Earnings		 -52 -74
Other Equity Adjustments		 14 12

Quarterly Balance Sheets for IperionX

No quarterly balance sheets for IperionX are available.

Annual Metrics and Ratios for IperionX

This table displays calculated financial ratios and metrics derived from IperionX's official financial filings.

Metric 2022 2023 2024
Growth Metrics		 - - -
Revenue Growth		 0.00% 23.30% 10.43%
EBITDA Growth		 0.00% 18.94% -25.22%
EBIT Growth		 0.00% 18.94% -25.22%
NOPAT Growth		 0.00% 18.94% -25.22%
Net Income Growth		 0.00% 18.94% -25.22%
EPS Growth		 0.00% 31.25% 9.09%
Operating Cash Flow Growth		 0.00% 30.81% 359.02%
Free Cash Flow Firm Growth		 0.00% 0.00% -16.28%
Invested Capital Growth		 0.00% 0.00% 104.91%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00%
Profitability Metrics		 - - -
Gross Margin		 -1,992.68% -441.50% -628.65%
EBITDA Margin		 -5,366.29% -3,527.98% -4,000.46%
Operating Margin		 -5,366.29% -3,527.98% -4,000.46%
EBIT Margin		 -5,366.29% -3,527.98% -4,000.46%
Profit (Net Income) Margin		 -5,366.29% -3,527.98% -4,000.46%
Tax Burden Percent		 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -254.39% -104.47%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -158.91% -73.72%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 84.72% 43.71%
Return on Equity (ROE)		 0.00% -169.67% -60.76%
Cash Return on Invested Capital (CROIC)		 0.00% -454.39% -173.28%
Operating Return on Assets (OROA)		 0.00% -76.50% -55.84%
Return on Assets (ROA)		 0.00% -76.50% -55.84%
Return on Common Equity (ROCE)		 0.00% -169.67% -60.76%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -84.83% -42.55%
Net Operating Profit after Tax (NOPAT)		 -15 -12 -15
NOPAT Margin		 -3,756.40% -2,469.58% -2,800.32%
Net Nonoperating Expense Percent (NNEP)		 0.00% -95.48% -30.74%
Cost of Revenue to Revenue		 2,092.68% 541.50% 728.65%
SG&A Expenses to Revenue		 762.07% 807.06% 827.13%
R&D to Revenue		 1,068.28% 1,669.48% 2,263.39%
Operating Expenses to Revenue		 3,373.61% 3,086.48% 3,371.80%
Earnings before Interest and Taxes (EBIT)		 -22 -17 -22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -22 -17 -22
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.05 0.03
Long-Term Debt to Equity		 0.00 0.03 0.02
Financial Leverage		 0.00 -0.53 -0.59
Leverage Ratio		 0.00 1.11 1.09
Compound Leverage Factor		 0.00 1.11 1.09
Debt to Total Capital		 0.00% 4.53% 2.82%
Short-Term Debt to Total Capital		 0.00% 1.78% 0.84%
Long-Term Debt to Total Capital		 0.00% 2.75% 1.98%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 95.47% 97.18%
Debt to EBITDA		 0.00 -0.06 -0.07
Net Debt to EBITDA		 0.00 0.63 1.45
Long-Term Debt to EBITDA		 0.00 -0.03 -0.05
Debt to NOPAT		 0.00 -0.08 -0.10
Net Debt to NOPAT		 0.00 0.90 2.07
Long-Term Debt to NOPAT		 0.00 -0.05 -0.07
Altman Z-Score		 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 0.00 7.74 13.62
Quick Ratio		 0.00 7.38 11.62
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -22 -25
Operating Cash Flow to CapEx		 134.38% 182.99% 281.62%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.00 0.02 0.01
Accounts Receivable Turnover		 0.00 2.17 0.43
Inventory Turnover		 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.12 0.09
Accounts Payable Turnover		 0.00 2.27 2.27
Days Sales Outstanding (DSO)		 0.00 168.59 845.74
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 160.99 160.49
Cash Conversion Cycle (CCC)		 0.00 7.60 685.25
Capital & Investment Metrics		 - - -
Invested Capital		 0.00 9.60 20
Invested Capital Turnover		 0.00 0.10 0.04
Increase / (Decrease) in Invested Capital		 0.00 9.60 10
Enterprise Value (EV)		 0.00 0.00 0.00
Market Capitalization		 0.00 0.00 0.00
Book Value per Share		 $0.00 $0.00 $0.20
Tangible Book Value per Share		 $0.00 $0.00 $0.20
Total Capital		 0.00 22 53
Total Debt		 0.00 0.98 1.49
Total Long-Term Debt		 0.00 0.59 1.04
Net Debt		 0.00 -11 -32
Capital Expenditures (CapEx)		 2.82 2.71 8.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -0.45 5.79
Debt-free Net Working Capital (DFNWC)		 0.00 11 39
Net Working Capital (NWC)		 0.00 11 38
Net Nonoperating Expense (NNE)		 6.46 5.23 6.55
Net Nonoperating Obligations (NNO)		 0.00 -11 -32
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -90.64% 1,059.47%
Debt-free Net Working Capital to Revenue		 0.00% 2,323.65% 7,131.93%
Net Working Capital to Revenue		 0.00% 2,246.27% 7,050.29%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.10)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 257.24M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.10)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 257.24M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 257.24M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 -12 -15
Normalized NOPAT Margin		 -3,756.40% -2,469.58% -2,800.32%
Pre Tax Income Margin		 -5,366.29% -3,527.98% -4,000.46%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for IperionX

No quarterly metrics and ratios for IperionX are available.

Frequently Asked Questions About IperionX's Financials

When does IperionX's financial year end?

According to the most recent income statement we have on file, IperionX's fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has IperionX's net income changed over the last 2 years?

In the past 2 years, IperionX's net income has ranged from -$21.84 million in 2024 to -$17.44 million in 2023, and is currently -$21.84 million as of their latest financial filing in 2024.

What is IperionX's operating income?
IperionX's total operating income in 2024 was -$21.84 million, based on the following breakdown:
  • Total Gross Profit: -$3.43 million
  • Total Operating Expenses: $18.41 million
How has IperionX revenue changed over the last 2 years?

Over the last 2 years, IperionX's total revenue changed from $401.05 thousand in 2022 to $546.03 thousand in 2024, a change of 36.2%.

How much debt does IperionX have?

IperionX's total liabilities were at $4.10 million at the end of 2024, a 82.8% increase from 2023, and a 82.8% increase since 2023.

How much cash does IperionX have?

In the past 1 years, IperionX's cash and equivalents has ranged from $11.94 million in 2023 to $33.16 million in 2024, and is currently $33.16 million as of their latest financial filing in 2024.

How has IperionX's book value per share changed over the last 2 years?

Over the last 2 years, IperionX's book value per share changed from 0.00 in 2022 to 0.20 in 2024, a change of 20.0%.


Related Companies

This page (NASDAQ:IPX) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners
Claim Your FREE Protection Guide
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...
American Alternative | Sponsored
Trump’s Top Secret $9 Trillion AI Superweapon
Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...
Brownstone Research | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
Trump Orders 'National Digital Asset Stockpile'
‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more traction
Crypto 101 Media | Sponsored
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...
Colonial Metals | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored